← Eichor
Condition: Haplo Identical Stem Cell Transplantation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Haplo Identical Stem Cell Transplantation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Ce
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT05664126
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells a
Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03520647
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Le
Phase 1/Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT03670966
Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06089850
Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC
Phase 1 · 1 location(s) · University Hospital, Geneva · NCT05066412
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With
Phase 2 · 35 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05126849
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.